FRONT ONCOL 润色咨询

Frontiers in Oncology

出版年份:2011 年文章数:14479 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    昨天 要没时间了 来自辽宁省

    偏重的研究方向:肿瘤
    经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2025-02-14 ms4000001757914888 来自辽宁

    偏重的研究方向:肿瘤
    经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2025-01-09 ms8000000124135786

    多久才能pubmed检索啊

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2025-01-13 shademei 来自山西省

    投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-12-23 ms1000000382468845 来自重庆

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤
    经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-01-01 ms4000001668897773 来自北京

    偏重的研究方向:肿瘤
    经验分享:23.12.27 submit 24.1.1 仍然initial validation

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-12-28 shademei

    偏重的研究方向:肿瘤
    经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-12-19 1469407fm39暂无昵称 来自石川县

    审稿速度:24.0 | 投稿命中率:50.0
    经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-10-25 ms1000001788822128 来自北京

    editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向:肿瘤<br>经验分享:投了一篇Meta,顺利接收,时间线如下: Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享,受益良多,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=昨天, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向:肿瘤<br>经验分享:第二次投了,妇科肿瘤方向,17天了仍是Editorial Assignment状态,副编辑仍未分配,朋友们你们的也这么慢吗?是杂志整体变慢了吗?我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:审稿周期太长了,将近11个月,胃癌蛋白组学的分层模型,刚开始邀请2个审稿人,结果有一个给了provoke,再次邀请花费了将近3个月,最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:我也是从投稿到现在已经4个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,还让我自己找编辑。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向:肿瘤<br>经验分享:胃癌的预后模型,发表周期比较长,11个月,中间有一个审稿人给了provoke,耽误了三个月,重新找的审稿人,但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享:从投稿到现在已经3个月,还没有给分配编辑,发邮件回复说没有找到合适的编辑,这都是借口。该期刊不知道遇到了什么困境,建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了,还没分配编辑,有邮件催了,但是还是每动静,比较担心,太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实践综述,个人觉得审稿速度挺快的。<br>一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。<br>后面就是漫长的返修等待,最后在前天录用了<br>我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海)]
    2024-12-10 ms3000001788822132 来自上海

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤
    经验分享:实践综述,个人觉得审稿速度挺快的。
    一审1个月左右就完成,我总共邀请了两位审稿人,两位都给了修改意见。
    后面就是漫长的返修等待,最后在前天录用了
    我是9月底投稿的总共耗时2个多月。

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分